| (Values in U.S. Thousands) | Mar, 2023 | Mar, 2022 | Mar, 2021 | Mar, 2020 | Mar, 2019 |
| Sales | 16,436 | 16,767 | 14,316 | 15,144 | 13,643 |
| Sales Growth | -1.98% | +17.12% | -5.47% | +11.00% | unch |
| Net Income | -1,330 | -981 | 2,278 | 1,386 | 1,501 |
| Net Income Growth | -35.66% | -143.05% | +64.41% | -7.69% | unch |
Xybion Digital Inc (XYBN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Xybion Digital Inc operates as a SaaS company dedicated to providing life sciences and health systems companies with software solutions to accelerate the transformation of medicines, devices, and diagnostic tests. It offers end-to-end cloud software as a SaaS (software as a service) for core business processes like research and development, testing laboratory operations, workplace and employee health and safety management with embedded compliance, quality, risk, and enterprise content management systems all on a single cloud and a single database. The majority of the Company's revenue is generated in the United States.
Fiscal Year End Date: 03/31